ERVK-19


Summary:

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
endogenous retrovirus group K member 19, envelopeHGNC:HGNC:3902619q11

GO terms in ERVK-19


Term TypeEvidence TypeGO Term IDGO Des.

Gene expression in normal tissue: ERVK-19

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in ERVK-19


DatabasePathway IDPathway Des.

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD125BIRB-7961
iGMDRD681SB-7439211
iGMDRD560MK-22061
iGMDRD594AZD-80551
iGMDRD20Embelin1
iGMDRD1036X17AAG1
iGMDRD79Gemcitabine1
iGMDRD382CEP-7011
iGMDRD564GSK-6503941
iGMDRD324CI-10401
iGMDRD450JNJ-268541651
iGMDRD176Decitabine1
iGMDRD352PD-03259011
iGMDRD18Cyclophosphamide1
iGMDRD396AS6012451
iGMDRD381Rucaparib1
iGMDRD173Epothilone B1
iGMDRD402AKT Inhibitor VIII1
iGMDRD472PF-5622711
iGMDRD552AZD-17751
iGMDRD42Vorinostat1
iGMDRD421AZD77621
iGMDRD946ML3201
iGMDRD87Epigallocatechin-3-monogallate2
iGMDRD561ABT-2631
iGMDRD779PRL-3 Inhibitor I1
iGMDRD546BMS-7548071
iGMDRD489GSK-4613641
iGMDRD462OSI-906 (Linsitinib)1
iGMDRD354Midostaurin1
iGMDRD112Methotrexate1
iGMDRD12Bicalutamide1
iGMDRD654SL 0101-11
iGMDRD659Avagacestat (BMS-708163)1
iGMDRD401Afatinib1
iGMDRD608Refametinib1
iGMDRD519GDC-09411
iGMDRD639YK 4-2791
iGMDRD66Doxorubicin1
iGMDRD117Docetaxel1
iGMDRD700AUY9221
iGMDRD291AC1NS4S01
iGMDRD131Erlotinib1
iGMDRD431NU-74411
iGMDRD602Foretinib1
iGMDRD399Selumetinib1
iGMDRD609BRD-K664538931

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in ERVK-19

​​​​